3vul Citations

Seven cysteine-deficient mutants depict the interplay between thermal and chemical stabilities of individual cysteine residues in mitogen-activated protein kinase c-Jun N-terminal kinase 1.

Biochemistry 51 8410-21 (2012)
Related entries: 3vud, 3vug, 3vuh, 3vui, 3vuk, 3vum

Cited: 10 times
EuropePMC logo PMID: 23020677

Abstract

Intracellular proteins can have free cysteines that may contribute to their structure, function, and stability; however, free cysteines can lead to chemical instabilities in solution because of oxidation-driven aggregation. The MAP kinase, c-Jun N-terminal kinase 1 (JNK1), possesses seven free cysteines and is an important drug target for autoimmune diseases, cancers, and apoptosis-related diseases. To characterize the role of cysteine residues in the structure, function, and stability of JNK1, we prepared and evaluated wild-type JNK1 and seven cysteine-deficient JNK1 proteins. The nonreduced sodium dodecyl sulfate-polyacrylamide gel electrophoresis experiments showed that the chemical stability of JNK1 increased as the number of cysteines decreased. The contribution of each cysteine residue to biological function and thermal stability was highly susceptible to the environment surrounding the particular cysteine mutation. The mutations of solvent-exposed cysteine to serine did not influence biological function and increased the thermal stability. The mutation of the accessible cysteine involved in the hydrophobic pocket did not affect biological function, although a moderate thermal destabilization was observed. Cysteines in the loosely assembled hydrophobic environment moderately contributed to thermal stability, and the mutations of these cysteines had a negligible effect on enzyme activity. The other cysteines are involved in the tightly filled hydrophobic core, and mutation of these residues was found to correlate with thermal stability and enzyme activity. These findings about the role of cysteine residues should allow us to obtain a stable JNK1 and thus promote the discovery of potent JNK1 inhibitors.

Reviews citing this publication (1)

  1. Human α-Galactosidase A Mutants: Priceless Tools to Develop Novel Therapies for Fabry Disease. Modrego A, Amaranto M, Godino A, Mendoza R, Barra JL, Corchero JL. Int J Mol Sci 22 6518 (2021)

Articles citing this publication (9)

  1. A Specific and Covalent JNK-1 Ligand Selected from an Encoded Self-Assembling Chemical Library. Zimmermann G, Rieder U, Bajic D, Vanetti S, Chaikuad A, Knapp S, Scheuermann J, Mattarella M, Neri D. Chemistry 23 8152-8155 (2017)
  2. H3.3K27M-induced chromatin changes drive ectopic replication through misregulation of the JNK pathway in C. elegans. Delaney K, Strobino M, Wenda JM, Pankowski A, Steiner FA. Nat Commun 10 2529 (2019)
  3. Impact of cysteine variants on the structure, activity, and stability of recombinant human α-galactosidase A. Qiu H, Honey DM, Kingsbury JS, Park A, Boudanova E, Wei RR, Pan CQ, Edmunds T. Protein Sci 24 1401-1411 (2015)
  4. Development of a cysteine-deprived and C-terminally truncated GLP-1 receptor. Underwood CR, Knudsen LB, Garibay PW, Peters GH, Reedtz-Runge S. Peptides 49 100-108 (2013)
  5. Protein engineering for improving the thermostability of tryptophan oxidase and insights from structural analysis. Yamaguchi H, Tatsumi M, Takahashi K, Tagami U, Sugiki M, Kashiwagi T, Kameya M, Okazaki S, Mizukoshi T, Asano Y. J Biochem 164 359-367 (2018)
  6. Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine. Kaur K, Xiong J, Sawant N, Agarwal S, Hickey JM, Holland DA, Mukhopadhyay TK, Brady JR, Dalvie NC, Tracey MK, Love KR, Love JC, Weis DD, Joshi SB, Volkin DB. J Pharm Sci 110 1054-1066 (2021)
  7. Phosphorylation- and nucleotide-binding-induced changes to the stability and hydrogen exchange patterns of JNK1β1 provide insight into its mechanisms of activation. Owen GR, Stoychev S, Achilonu I, Dirr HW. J Mol Biol 426 3569-3589 (2014)
  8. Proposing the Promiscuous Protein Structures in JNK1 and JNK3 for Virtual Screening in Pursuit of Potential Leads. Sailapathi A, Murugan G, Somarathinam K, Gunalan S, Jagadeesan R, Yoosuf N, Kanagaraj S, Kothandan G. ACS Omega 5 3969-3978 (2020)
  9. Rational Design of the Soluble Variant of l-Pipecolic Acid Hydroxylase using the α-Helix Rule and the Hydropathy Contradiction Rule. Shinoda S, Itakura A, Sasano H, Miyake R, Kawabata H, Asano Y. ACS Omega 7 29508-29516 (2022)